Hepatitis B
📧 Sign up to get email alerts when something new happens for Hepatitis B.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2010-10-15FDA Approved: BARACLUDE — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
The FDA approved a supplemental application for BARACLUDE (entecavir) submitted by E.R. Squibb & Sons, L.L.C.
-
FDA approval · 2010-03-03FDA Approved: PEGASYS — Supplemental Application (pharmaand GmbH)
FDA approved a supplemental application for PEGASYS (peginterferon alfa-2a) from pharmaand GmbH, approving an update to the biologics licens…
-
FDA approval · 2009-02-25FDA Approved: BARACLUDE — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
FDA approved a supplemental application for BARACLUDE (entecavir) submitted by E.R. Squibb & Sons, L.L.C.
-
FDA approval · 2009-02-25FDA Approved: BARACLUDE — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
The FDA approved a supplemental application for BARACLUDE (entecavir) submitted by E.R. Squibb & Sons, L.L.C.
-
FDA approval · 2008-07-25FDA Approved: BARACLUDE — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
The FDA approved a supplemental application for BARACLUDE (entecavir) submitted by E.R. Squibb & Sons, L.L.C., indicating an update to its r…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2008-06-03FDA Approved: BARACLUDE — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
The FDA approved a supplemental application for Baraclude (entecavir) submitted by E.R. Squibb & Sons, L.L.C.
-
FDA approval · 2008-06-03FDA Approved: BARACLUDE — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
FDA approved a supplemental application for Baraclude (entecavir) submitted by E.R. Squibb & Sons, L.L.C.
-
FDA approval · 2007-07-24FDA Approved: BARACLUDE — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
FDA approved a supplemental application for BARACLUDE (entecavir) submitted by E.R. Squibb & Sons, L.L.C. The approval updates BARACLUDE's l…
-
FDA approval · 2007-03-27FDA Approved: BARACLUDE — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
FDA approved a supplemental application for Baraclude (entecavir) filed by E.R. Squibb & Sons, L.L.C.
-
FDA approval · 2007-03-27FDA Approved: BARACLUDE — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
The FDA approved a supplemental application for BARACLUDE (entecavir) from E.R. Squibb & Sons, L.L.C. The action updates or expands the prod…
-
FDA approval · 2007-02-23FDA Approved: BARACLUDE — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
FDA approved a supplemental application for BARACLUDE (entecavir) filed by E.R. Squibb & Sons, L.L.C.; details of the supplemental approval …
-
FDA approval · 2006-06-13FDA Approved: EPIVIR — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for EPIVIR (lamivudine) submitted by ViiV Healthcare Company. Lamivudine is used to treat HIV-1 infe…